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Abstract
Background:  The involvement of different NMDA receptor (NMDAR) subunits has been
implicated in several forms of synaptic plasticity. However, it is still controversial to what extent
the involvement is specific, and little is known about the role of NMDAR subunits in certain "non-
conventional" forms of plasticity. In this study we used subunit-specific blockers to test the roles
of NR2A- and NR2B-containing NMDARs in a type of chemical long-term depression (LTD)
induced by brief bath application of the NMDAR agonist NMDA to hippocampal slices from 12–18
days old rats. For comparison, we also examined other forms of plasticity, including a "slow LTD"
induced by 0.1 Hz stimulation under low Mg2+ conditions as well as long-term potentiation (LTP).
Results: A blocker of NR2A-containing NMDARs, NVP-AAM077 (NVP), substantially reduced the
two forms of studied depression whereas blockers of NR2B-containing NMDARs, Ro25-6981 (Ro)
or Ifenprodil (Ife), had no significant effect on them. LTP appeared to be more sensitive as it was
fully blocked by NVP and partially blocked by Ro or Ife. However, the blocking effects of NVP could
be counteracted by general amplification of NMDA responses by lowering Mg2+ concentration in
the perfusion solution. Applying NVP or Ro/Ife on isolated NMDA-EPSPs recorded in low Mg2+
solution reduced responses to about 70% and 20% of initial size, respectively, whereas
coapplication of both blockers almost completely abolished the responses. Additionally, NMDA
application caused depotentiation of a pathway with prior tetanus-induced LTP, and NVP but not
Ro/Ife substantially prevented that depotentiation as well as the chemical LTD of the control
pathway. A second tetanus on the LTP pathway induced repotentiation which was fully blocked by
NVP but partially blocked by Ro/Ife.
Conclusion: All of these results on hippocampal slices from young rats can be explained by a
simple model, in which NR2A subunits dominate over NR2B subunits with respect to both
plasticity and NMDAR-mediated responses. The model suggests that Ca2+  influx into the
postsynaptic spine via different subtypes of NMDARs makes up a "final common pathway",
controlling synaptic plasticity by its magnitude and temporal pattern regardless of the source.
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Background
Long-term potentiation (LTP) and long-term depression
(LTD) are forms of activity-dependent synaptic plasticity
believed to play important roles in learning and memory
processes. Experimentally, LTP is induced by brief high
frequency activation of presynaptic axons (e.g. 100 Hz, 1
s) or by pairing presynaptic activation with postsynaptic
depolarization, resulting in a long-lasting increase of the
synaptic efficacy [1-4]. LTD, on the other hand requires
activation at a moderate frequency (e.g. 1 Hz, 15 min) or
paring presynaptic activation with lower levels of depo-
larization, leading to a long-lasting decrease in synaptic
efficacy [5,6]. Both types of plasticity depend on NMDA
receptor (NMDAR) activation as a first step, evidenced by
the fact that they are fully blocked when NMDAR antago-
nists, such as AP5, are present during the induction. Addi-
tionally, in many brain regions synaptic potentiation as
well as depression can be induced by direct application of
NMDA, the specific agonist of NMDAR. While fast appli-
cation of NMDA, e.g. by pressure injection or iontophore-
sis, may lead to LTP-like phenomena [7,8], bath
application of NMDA for several minutes has been shown
to induce a persistent depression, believed to be equiva-
lent to stimulus-induced LTD [9]. Our previous work on
NMDA-induced plasticity has demonstrated multiple
changes after NMDA application, some of which may be
related to LTP/LTD while others may represent different
forms of synaptic plasticity [10].
NMDAR are tetrameric, or possibly pentameric, com-
plexes containing at least one NR1 receptor subunit and
two or more NR2 units [11-13]. NR1 subunits distribute
ubiquitously in the mammalian central nervous system
and are required for receptor function [14]. NR2 subunits
exist in different isoforms NR2A, NR2B, NR2C and NR2D.
The composition of the receptor in terms of these units
determines some important properties of the receptor,
including kinetics, open channel conductance and voltage
dependence [14]. The balance between 2A and 2B changes
during development, with NR2B-type NMDARs being
prominent in young animals while NR2A-type NMDARs
become more important with increasing age [15,16]. A
critical issue is to what extent the different NMDAR subu-
nits are involved in different forms of NMDA-dependent
synaptic plasticity such as LTP and LTD. Whereas an early
study suggested a difference between NR2A-B on one
hand and NR2C-D on the other hand [17], later work has
emphasized the distinction between NR2A and NR2B.
Thus, it has been shown that LTP in the hippocampus is
specifically related to NR2A-containing NMDARs [18].
On the other hand, LTD in both hippocampus and per-
irhinal cortex was shown to specifically rely on NR2B-con-
taining NMDARs [18,19]. Moreover, it was reported that
the erasure of LTP, referred to as "depotentiation", was
due to the involvement of NR2A subunits [19]. Even so,
the idea of subtype specificity has also been questioned,
suggesting that the important thing for LTP is the degree
and temporal character of the Ca2+ influx, not the actual
subtype of receptor involved [20]. Studies in some other
brain regions than hippocampus, such as anterior cingu-
late cortex (ACC), also showed that both NR2A- and
NR2B-type NMDARs contributed to LTP [21].
As shown above, data on subunit specificity exist for proc-
esses such as LTP and LTD as well as depotentiation, the
"erasure counterpart" of LTP. However, little is known
about the role of NMDAR subtypes in synaptic plasticity
induced by direct application of NMDA. Some previous
work studied the immediate effects of NMDA in terms of
depolarization or the associated depression of EPSPs in
connection with subunit-specific blockers, but the con-
centration of NMDA in those cases was usually much
smaller than needed to get persistent depression of EPSPs
[22,23]. We were therefore eager to study the issue of
NMDAR subunit specificity in connection with the above-
mentioned LTD model, using NMDA application instead
of stimulation as the induction event. The results sug-
gested an essential role for NR2A- rather than NR2B-type
NMDARs and were further complemented by measure-
ments on isolated NMDA-EPSPs. This prompted us to
investigate other plasticities such as LTP, depotentiation
and a form of stimulus-induced, slowly developing LTD.
Taken together, our results imply a predominant NR2A-
dependency in all of the cases. However, it appeared that
NR2B subunits also contributed under certain conditions.
Results
In the first set of experiments, we examined the effects of
selective antagonists of NR2A and NR2B subunits on
NMDA-induced plasticity. While a previous study in this
lab has revealed multiple changes induced by NMDA
application, some of which are transient, here we were
mainly interested in the effects on the sustained depres-
sion obtained about one hour after NMDA treatment.
This plasticity will be referred to as NMDA-induced LTD
in the following, as it is believed to be equivalent to stim-
ulus-induced LTD. As blockers we used NVP-AAM077
(NVP) for NR2A-containing NMDARs and either Ro25-
6981 (Ro) or Ifenprodil (Ife) for NR2B-containing
NMDARs (see Methods).
NMDA-induced LTD
NVP (0.4 μM) or Ro (0.5 μM)/Ife (3 μM) was applied at
least 1 h before NMDA application and no influence on
baseline level was observed. Fig. 1 illustrates NMDA-
induced LTD under normal conditions compared to sim-
ilar experiments treated with NVP or Ro/Ife. The control
experiment in Fig. 1A shows that brief (4 min) application
of NMDA (30 μM) resulted in a complete extinction of
EPSPs, followed by a recovery and a stable, depressed levelBMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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about 1 h later, i.e. NMDA-induced LTD. On average,
EPSPs were depressed to 70 ± 7%, n = 15, of the initial
baseline level. As seen in Fig. 1B, blockade of NR2B recep-
tors by Ro/Ife did not cause any detectable change in
NMDA-induced plasticity as revealed by a nearly identical
time course of the depression. In this case, EPSPs were
depressed to 72 ± 6% (n = 12) of baseline, which is almost
the same as in the control situation (p > 0.1, see also bar
diagram in Fig. 1D). Fig. 1C shows the situation in the
presence of NVP, yielding a different result. It can be seen
that the extinction phase was shorter with about 10 min
to half recovery compared to about 30 min in the normal
case. Moreover, the LTD was nearly blocked by this NR2A
inhibitor, amounting to 92 ± 3% (n = 10, p < 0.05) of
baseline. Bar diagram in Fig. 1D summarizes the quantita-
tive data.
Isolated NMDA-EPSPs
Isolated NMDAR-mediated EPSPs were recorded with the
help of low Mg2+ solution. Since frequent activation of
NMDARs can cause a successive decrease of the response
amplitude, the stimulus frequency was kept low, usually
at one per minute. After recording such NMDA-EPSPs for
30–60 min, the NR2A antagonist NVP (0.4 μM) was
applied leading to a substantial reduction of responses, on
the average down to 19 ± 3% of baseline (n = 5). Subse-
quent application of Ro (0.5 μM) depressed the responses
further down to 4.6 ± 2.4% of the original baseline.
Finally, AP5 (50 μM) solution, assumed to block all types
of NMDARs, was applied. The response in AP5 was used
to define the zero response (see Methods for the concept
of the "nonsynaptic potential"). It appears that NR2A-
and NR2B-type NMDARs mediate most of the NMDA-
EPSP, with the dominance of NR2A-containing receptors
(see Fig. 2A). Our results were corroborated by alternative
Relative contributions of NR2B and NR2A subunits to iso- lated NMDA-EPSPs Figure 2
Relative contributions of NR2B and NR2A subunits 
to isolated NMDA-EPSPs. (A) Isolated NMDA-EPSPs 
obtained in a low Mg2+ solution (0.1 mM; n = 5). (i) After 
recording baseline responses, defining the 100% level (1), 
applying NR2A inhibitor NVP-AAM077 (0.4 μM) leads to a 
substantial reduction of the isolated NMDA response (2). 
Adding NR2B inhibitor Ro25-6981 (0.5 μM) further 
depresses the responses down to near zero (3). Subsequent 
perfusion with AP5 (50 μM) fully blocks the synaptic 
responses and values obtained in this solution are taken as 
zero level (4). (ii) Traces 1–3 plotted together after subtrac-
tion of the zero level. (iii) Bar diagram quantifying the reduc-
tions of NMDA-EPSPs after sequentially adding the two 
subunit-specific blockers, NVP-AAM077 and Ro25-6981. (B) 
Similar plots for another set of experiments where the two 
blockers were applied in a different order (n = 6). The bar 
diagrams show data as mean ± S.E.M. Calibrations: 0.1 mV, 
20 ms.
Roles of NR2B and NR2A subunits in NMDA-induced LTD Figure 1
Roles of NR2B and NR2A subunits in NMDA-induced 
LTD. (A) NMDA application (30 μM, 4 min) under normal 
conditions causes initial extinction of EPSPs, followed by 
recovery and stabilization (n = 15). (B) NR2B inhibitors, 
Ro25-6981 (0.5 μM) or Ifenprodil (3 μM), do not affect 
NMDA-induced plasticity (n = 8+4 = 12). (C) In presence of 
NR2A inhibitor, NVP-AAM077 (0.4 μM), NMDA effects are 
different compared with control situation, with a shorter 
recovery phase and much less depression (n = 10). (D) Bar 
diagram reveals LTD at 60 min after NMDA application as 
percentage of the initial baseline under the different experi-
mental conditions in A-C. Data are given as mean ± S.E.M. 
Black bars in A-C indicate the duration of drug treatment. 
Values are shown averaged for 2 min periods. Inserts illus-
trate EPSP-traces taken at the indicated time points (a, b). 
Calibrations: 0.5 mV, 10 ms.BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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experiments in which the same concentrations of drugs
were applied but in a different order. Thus we first applied
Ro, then NVP and finally switch the perfusion to AP5
solution (Fig. 2B). It was found that Ro caused a partial
reduction of the NMDA response, down to 68 ± 6% of
baseline (n = 6), whereas subsequent application of NVP
blocked virtually all of the response, down to 2.7 ± 1.8%
of baseline. Similar results were also obtained with 3 μM
Ifenprodil instead of Ro (data not shown). Taken
together, our data suggest that NR2A- and NR2B-type
receptors contribute to about 70–80% and 20–30%,
respectively, of isolated NMDAR-mediated EPSPs. All
blocking effects were statistically significant (p < 0.01)
whereas the residual responses after adding both blockers
did not differ from zero (p > 0.1).
Stimulus-induced LTD
The suggested dominant role for NR2A subunits in
NMDA-induced LTD seems to contradict previous studies
implying a major role for NR2B units in stimulus-induced
LTD [18,19]. To resolve this inconsistency we wished to
investigate the role of NR2A and NR2B subunits in stimu-
lus-induced LTD in our experimental situation. Since LTD
induced by conventional 1–2 Hz stimulation [5,6] was
relatively small in our hands we induced LTD by test rate
stimulation (0.1 Hz, for a period of 1–2 h) in a low Mg2+
solution. In this situation LTD is facilitated by the easier
entry of Ca2+ through NMDARs. Previous work in our lab
has shown that this experimental model provides depres-
sion down to 40–50% of initial baseline [24]. The depres-
sion will be refered to as "slow LTD" in the following.
Fig. 3A illustrates the three stages of a "slow LTD" experi-
ment under normal conditions. Measuring dual EPSPs via
an early and a late time window allowed both AMPA and
NMDA components to be assessed (see Methods). Ini-
tially, a high concentration of AP5 (50 μM) was present to
block the NMDA component, the remaining AMPA-EPSP
being used to define the preinduction baseline. Next, AP5
was washed out to allow expression of an NMDA
response, which caused a gradually developing depression
of both AMPA and NMDA components. Finally, AP5 was
reintroduced, leading to a depressed level of AMPA-EPSPs
by a factor of 49 ± 5% as compared to the initial baseline
(n = 8). To test the role of NR2A- and NR2B-type receptors
in the induction of this "slow LTD", either NVP or Ro/Ife
was introduced in the AP5-free solution (Fig. 3B, C). Our
results showed that LTD was uneffected by Ro/Ife, but was
largely blocked by NVP, the AMPA-EPSP obtained after
the induction period amounting to 45 ± 4% (n = 8, p >
0.1) and 93 ± 4% (n = 7, p < 0.001) of baseline level,
respectively. The results are summarized in Fig. 3D.
LTP, depotentiation and repotentiation
Different induction pathways have previously been sug-
gested for LTP versus LTD, so we went on to test this pos-
sibility in our experimental situation. LTP experiments
were therefore carried out in normal solution in the pres-
ence of either NR2A or NR2B inhibitors. Fig. 4A illustrates
LTP induced by three successive tetani (100 Hz, 100
impulses each) in the control situation. When measured
at 60 min after induction, the EPSP was increased to a
level of 179 ± 4% of baseline (n = 10). Consistent with
previous findings [18,19], LTP was completely blocked by
the prior treatment with NVP (Fig. 4C), the level after
tetanization amounting to 98 ± 3% of baseline (n = 5, p <
0.001). Moreover, the degree of LTP was also substantially
reduced by Ro/Ife (Fig. 4B), the potentiated level amount-
ing to 126 ± 5% of baseline (n = 6, p < 0.001 for both the
blocking effect and the remaining LTP). These results sug-
gest that both NR2A and NR2B subunits contribute to LTP
under normal conditions.
Roles of NR2B and NR2A subunits in stimulus-induced LTD Figure 3
Roles of NR2B and NR2A subunits in stimulus-
induced LTD. (A) A "slow LTD" is induced by 0.1 Hz test 
rate stimulation for 90 min in a low Mg2+ solution. The 
experiment consists of preinduction baseline level in pres-
ence of a high concentration of AP5 (50 μM), induction 
period in AP5-free solution, and established LTD after 
reintroduction of high AP5. AMPA component (black sym-
bols) and NMDA component (gray symbols) are plotted as 
functions of time, each point indicating the average in 2 min 
(n = 8 experiments). (B) A similar result is obtained in the 
same type of experiment but treated with Ro25-6981 (0.5 
μM; n = 8) during the induction period. (C) The "slow LTD" 
is substantially blocked when NVP-AAM077 (0.4 μM; n = 7) 
is present under induction in AP5-free solution. (D) Bar dia-
gram shows the "slow LTD" at 30 min after reintroducing 
AP5, plotted as percentage of the preinduction level under 
the three different experimental situations in A-C. Data are 
mean ± S.E.M. Black bars in A-C indicate the duration of drug 
treatment. Inserts show the EPSP-traces taken at the indi-
cated time points (a-d) and the timing of the measurements 
for AMPA and NMDA components (0–1.5 ms after fiber vol-
ley and at 35–45 ms, respectively; see bars below traces). 
Calibrations: 0.2 mV, 20 ms.BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
Page 5 of 12
(page number not for citation purposes)
We next performed experiments with NMDA application
one hour after LTP induction as above, leading to a
depression of the naive pathway and a depotentiation of
the LTP-treated one (Fig. 5A). A second tetanus was
applied to the LTP pathway at 90 min after the NMDA
application leading to a repotentiation. Synaptic plasticity
was quantified using either the plain test response or test/
control ratio (see Materials and Methods), yielding some-
what different values. The properties of these similar but
nonequivalent estimates are further considered in Discus-
sion. Under normal conditions, the potentiated level of
178 ± 9% was reduced to 94 ± 7% (n = 12) of the baseline
by NMDA application, revealing that depotentiation
occurred (Fig. 6B, values marked a). Subsequent tetaniza-
tion restored the level to 140 ± 10%. When we expressed
the values as test/control ratio, the potentiation
amounted to 181 ± 6% whereas the depotentiation
resulted in 136 ± 4%. Repotentiation finally gave a ratio
as high as 204 ± 11% (Fig. 6C, values marked a).
In similar experiments, either NR2A or NR2B inhibitor,
i.e. NVP or Ro/Ife, was applied just after the first tetanus
(Fig. 5B, C, Fig. 6A values marked b-c), assuring that the
drug did not affect induction of the first LTP whereas it
had access to all the following plasticity. We found that
LTP expression was not affected by either of the blockers,
while the subsequent NMDA-induced depotentiation/
depression was substantially prevented by NVP (n = 5, p <
0.01) but not Ro/Ife (n = 6, p > 0.1). The second tetanus
Roles of NR2B and NR2A subunits in depotentiation and  repotentiation after LTP Figure 5
Roles of NR2B and NR2A subunits in depotentiation 
and repotentiation after LTP. (A) LTP is induced by 
three successive tetani (100 Hz, 100 impulses each) leading 
to a near doubling of the EPSP. Subsequent application of 
NMDA (30 μM, 4 min) leads to persistent depression of the 
control pathway (gray symbols) and depotentiation of the 
test pathway (black symbols). Secondary tetanization of the 
test pathway causes a repotentiation, lifting the test 
responses back to a potentiated level (n = 12). (B) and (C) 
show similar experiments but treated with Ro25-6981 (0.5 
μM; n = 4)/Ifenprodil (3 μM; n = 2) (total n = 6) or NVP-
AAM077 (0.4 μM; n = 5) shortly after LTP induction. Both 
depotentiation and repotentiation are preferentially attenu-
ated by NVP-AAM077 as compared to Ro25-6981/Ifenprodil. 
Arrows indicate the tetani. Black bars indicate the duration 
of drug application.
Roles of NR2B and NR2A subunits in LTP Figure 4
Roles of NR2B and NR2A subunits in LTP. (A) LTP 
induced by three successive tetani (100 Hz, 100 impulses 
each) in normal solution. The EPSP is potentiated to a near 
doubling of the initial response. Test pathway (black symbols) 
and control pathway (gray symbols) are plotted as functions 
of time, each point indicating the average in 1 min (n = 10 
experiments). (B) LTP is partially blocked by Ro25-6981 (0.5 
μM; n = 2)/Ifenprodil (3 μM; n = 4) (total n = 6). (C) LTP is 
fully prevented when NVP-AAM077 (0.4 μM) is present (n = 
5). (D) Bar diagram summarizes the data in A-C with mean ± 
S.E.M. LTP is measured at 60 min after tetanization relative 
to the initial baseline. Arrows in A-C indicate the tetani. 
Black bars indicate the duration of drug application. Inserts 
illustrate EPSP-traces taken at the indicated time points (a, b). 
Calibrations: 0.5 mV, 20 ms.BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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following NMDA application failed to repotentiate the
responses in presence of NVP. Compared to the normal
situation, repotentiation only occurred partially under the
treatment with Ro/Ife.
Compensatory role of NR2B subunits in facilitation 
experiments
It seems from the above that NR2A subunits are essential
for the induction of all types of synaptic plasticity we
tested here. Alternatively, the blocking effect of NVP could
be unspecific and merely due to the fact that the total size
of the NMDA response is reduced below a threshold level.
The NMDA-EPSP experiment in Fig. 2 illustrates that
although NR2A subunits are responsible for a large por-
tion of the EPSP, NMDA responses still have a significant
NR2B-mediated part, amounting to 20–30%. Moreover,
low concentration of AP5 (5 μM), mimicked the NVP
effect on both NMDA responses and "slow LTD", suggest-
ing that there was a threshold effect (n = 3, not illus-
trated). To test the possibility that the amount of available
NMDARs is the crucial factor for inducing synaptic plastic-
ity and so whether NR2B subunits could take over the role
of NR2A subunits in presence of NVP, we tried to facilitate
induction of some of these NMDA-dependent synaptic
plasticities by lowering Mg2+ concentration in the per-
fusion solution. First we tested the effect of NVP on
NMDA-induced LTD in 0.1 instead of 1.3 mM Mg2+ solu-
tion. Fig. 7A, B show that NMDA application was able to
induce a substantial LTD under this condition, the
responses being depressed down to 64 ± 6% of the base-
line level (n = 6, p < 0.01), similar to the control experi-
ment (see Fig. 1A). We next induced "slow LTD" in 0.01
mM Mg2+ solution in presence of NVP (reasoning that
unblocking might be incomplete with the 0.1 mM Mg2+
otherwise used) and found that activation of NMDARs
caused a significant depression in this case as well (Fig.
7C, D), down to 61 ± 5% of baseline (n = 7, p < 0.001).
We also carried out additional LTP experiments in low
Mg2+ solution (0.1 mM) to boost the induction process. It
can be noted that a small LTP was induced under the effect
of NVP, 119 ± 4% (n = 7, p < 0.01; see Fig. 7E, F). The
results suggest to us that NR2B-type receptors are capable
of supporting the induction of these types of synaptic
plasticity under the blockade of NR2A-type receptors.
Discussion
The present study adds information to the contentious
issue of NR2A versus NR2B involvement in different
forms of NMDA-dependent plasticity. In our case of 12–
18 days old rats, there was an overweight for NR2A
involvement in all of the plasticities examined: NMDA-
induced LTD, "slow LTD", LTP, NMDA-induced depoten-
tiation, and repotentiation. However, under certain con-
ditions we were able to show that NR2B subunits also
contribute. The results are consistent with our finding that
isolated NMDA-EPSPs contain both NR2A- and NR2B-
related portions but with a predominant contribution via
NR2A subunits.
Comparison with previous studies
Though our gathered data on NR2 subunit involvement
form a coherent picture, it is at odds with some previous
studies demonstrating subunit specificity for certain
forms of plasticity. For instance, NR2A inhibitor NVP was
found to block hippocampal LTP but not LTD, or even
Summary of depotentiation and repotentiation effects Figure 6
Summary of depotentiation and repotentiation 
effects. (A) Key, defining the measurements used. The 
experiment model indicates the three types of plasticity, LTP, 
depotentiation, and repotentiation, subjected to measure-
ments at times (1), (2) and (3), respectively. Additionally, 
there are three types of experiment with different drug 
treatment: normal (n = 12), NR2B block (by Ro25-6981/Ifen-
prodil, n = 6) and NR2A block (by NVP-AAM077, n = 5), 
denoted a-c and corresponding to panels A-C in Fig. 5 (same 
primary data used). Since drugs were applied after LTP induc-
tion only depotentiation and repotentiation were subjected 
to the specific subunit blockers. (B) Values of field EPSPs are 
estimated as test responses in percentage of initial baseline 
under the three different experimental conditions (a-c) and 
time points (1–3). (C) Same as B but values are calculated as 
the ratio between test and control responses for the three 
types of experiment. Data are expressed as mean ± S.E.M.BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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converted LTP into LTD in some situations [18]. Our
results agree as far as the blocking effect on LTP is con-
cerned but disagree with respect to the lack of effect on
LTD. Some other studies also support the idea of a critical
role for NR2A-type receptors in LTP [19,22], especially in
adult animals [25]. With respect to NR2B, it can be noted
that Ro/Ife was found to selectively block LTD with no
effect on LTP [18] whereas in our case the only positive
effect of Ro/Ife on synaptic plasticity was a partial block-
ade of LTP. Another study claiming NR2B involvement in
LTD described that Ro/Ife blocked LTD that was obtained
in the presence of glutamate uptake inhibitors [19]. How-
ever, several other studies concluded that both types of
subunits contribute to LTP or LTD [20,21,26,27].
The obligatory role of NR2B in LTD as evidenced by some
of the previous work has been questioned by a recent
study with contributions from several research groups,
which showed that neither Ro nor Ife could prevent LTD
[28]. Another recent publication demonstrated that NVP
affected both LTP and LTD, but Ro only partially blocked
LTP with no effect on LTD [29]. These results are in line
with the present findings, although the protocols for
inducing LTD are different. Previous work in our lab has
demonstrated a comparability of standard low frequency
stimulation (LFS)-induced LTD with slow LTD [24], but
further investigations will be needed to resolve this issue.
The present result of a similar receptor dependence in
these two types of LTD seems to support that they may
share a common mechanism. The previously reported
necessity of a glutamate uptake inhibitor for successful
LTD experiments [19], used as an argument for NR2B
involvement, has also been questioned since blockade of
NR2B-type receptors did not affect the induction of LTD
either with or without the drug [29].
While we have no in-depth explanation for the differences
among results, it can be noted that experimental parame-
ters often vary between the studies with respect to animal
species and age, brain area used, type of preparation and
recording type, composition of solutions, temperature
and protocols for inducing plasticity. Which of these is
most critical is hard to judge but biological factors ought
to be basic. For instance, properties of LTP or LTD may dif-
fer between various brain regions [30,31]. It is also worth
to mention that the experimental animals we used to
investigate synaptic plascitity were around two weeks old.
At this age, the composition of NMDA receptors on syn-
apses is believed to undergo developmental changes, with
the NR2B subunit in the receptor complex being replaced
by NR2A subunit. Previous studies have shown that in the
neonatal brain, NMDA receptors are composed nearly all
by NR2B subunits and that the expression of NR2A starts
at 6–10 days postnatal age. The shift from NR2B to NR2A
subunit leads to a dominant contribution of NR2A subu-
nits to the NMDA receptor in the adult brain [14,32]. It is
a bit unexpected that our 12–18 day rats already have a
larger portion of NR2A- than NR2B-type receptors. It
seems from our results that the shift process goes rather
quick once it starts. Similar tests on one-week postnatal
rats should be needed in future studies. In the following
we will discuss principles that might govern the triggering
Facilitated induction of plasticity overrides the blockade by  NVP-AAM077 Figure 7
Facilitated induction of plasticity overrides the block-
ade by NVP-AAM077. (A) Blocking effect of NVP-
AAM077 on NMDA-induced LTD (see Fig. 1C) is overcome 
by lowering Mg2+ concentration (0.1 instead of 1.3 mM; n = 
6). (B) Bar diagram shows NMDA-induced LTD in different 
Mg2+ solutions. Dashed bar is control data from Fig. 1D. (C) 
In a "slow LTD" experiment, similar to that in Fig. 3C, lower-
ing the concentration of Mg2+ in the perfusion solution (0.01 
instead of 0.1 mM) helps with the induction of "slow LTD" in 
presence of NVP-AAM077 (0.4 μM; n = 7). (D) Bar diagram 
reveals the "slow LTD" induced in different Mg2+ solutions. 
Dashed bar is control data from Fig. 3D. (E) Similarly, using 
low Mg2+ solution (0.1 instead of 1.3 mM) in LTP experi-
ments (compare Fig. 4C) enables a small potentiation of 
EPSPs under inhibition of NR2A subunits by NVP-AAM077 
(n = 7). (F) Bar diagram shows LTP induced in different Mg2+ 
solutions. Dashed bar is control data from Fig. 4D. Data are 
shown as mean ± SEM. Inserts show the EPSP-traces taken at 
the indicated time points (a-d). Calibrations: 0.5 mV (A, E), 
0.2 mV (C), 20 ms.BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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of NMDA-dependent synaptic plasticity without delving
into details.
Unified or diversified triggering of plasticity?
Let us consider two extremes, naming them as "unified"
and "diversified" triggering. In unified triggering we imag-
ine that sources of Ca2+ act in a cooperative manner, their
contributions summing together into a final common
pathway. The strength and temporal pattern of the latter
signal determine the resulting plasticity. Even so, certain
receptor subtypes may be preferentially involved depend-
ing on the induction pattern. The summation might be
achieved via the total Ca2+ concentration in a common
compartment, i.e. the spine. Alternatively, target enzymes
near the spine membrane could be sensitive to local entry
of Ca2+ but without any systematic relation between the
distribution of receptors and enzymes. In diversified trig-
gering, on the other hand, NMDAR subtypes and target
enzymes are assumed to have specific distributions in the
spine membrane and activation is assumed to occur
locally. In the extreme case, each type of NMDAR would
be strictly linked, via the proper enzyme, to a certain form
of plasticity, e.g. potentiation or depression. The induc-
tion pattern would then determine which plasticity is
induced by activating a certain subarea of the spine, char-
acterized by a special receptor-enzyme combination.
So where do the present data fit in on the unified-diversi-
fied axis? In view of the similar overwight for NR2A in the
various forms of plasticity as well as in the composition of
isolated NMDA-EPSPs, we conclude that it is near the
"unified end". According to this idea, one could imagine
that if one receptor is blocked and thus fails to induce a
certain form of plasticity, the other type of receptor could
take over its role, provided that conditions for inducing
plasticity are generally favorable. In fact, this is what was
observed in our facilitation experiments where NR2A was
blocked by NVP. Thus, in the presence of NVP, both types
of LTD as well as LTP could be induced by sufficiently low-
ering the Mg2+  concentration. Similar, or analogous
results have also been reported in other studies. For
instance, LTD recorded in cells in ACC, was blocked by
either NR2A or NR2B inhibitors suggesting involvement
of both receptor types. When cells were depolarized to
higher levels, LTD could be induced again despite block-
ade of one receptor type, demonstrating that both types
were actually capable of supporting LTD induction [33].
In another study, cited above, the trigger mode appeared
to be at the other extreme, i.e. diversified triggering [18].
In this case, NR2A- and NR2B-type receptors were unable
to substitute for each other but functioned as individual,
antagonistic controllers of the polarity of the synaptic
change. For instance, it was found that blockade of the
NR2A-containing population altered the response to LTP-
inducing stimuli in such a way that LTD was produced
instead of LTP. This was explained by assuming that LTP-
inducing stimuli normally activate both NR2A- and
NR2B-type receptors, and so might induce both LTP and
LTD, but yielding potentiation as net result. According to
the proposed scenario, blockade of NR2A-type receptors
would then lead to unmasking of the LTD. However, there
was no clear explanation of the results in terms of linkage
between receptor and enzyme distributions. With respect
to receptor distribution, another previous study consid-
ered LTD to be induced via NR2B-containing NMDARs
located extrasynaptically because of the need for the pres-
ence of glutamate uptake inhibitors [19]. Whether,
according to this result, the enzymes causing LTD would
also have to be located extrasynaptically is not clear but
we surmize so. However, it is still questionable how an
extrasynaptic LTD-generating mechanism could fit with
the well established input specificity of LTD. It seems to us
that generation of LTP or LTD in local membrane regions
would have to occur within the spine membrane for the
simple reason of input specificity. Notably, it has been
demonstrated that both NR2A-type and NR2B-type recep-
tors exist both intra- and extrasynaptically [16].
As mentioned, our data support the idea of unified trigger-
ing as several other studies do, even though details in the
blocking profiles of NVP and Ro/Ife differ [20,21,27,33].
One of our results that might be hard to explain within
this framework is the substantial blockade of LTP by Ro/
Ife, despite the fact that NR2B-containing receptors con-
tributed to a relatively small fraction of the NMDA
response. In fact this blockade could be on account of
diversified triggering to some extent. However, a specific
coupling between NR2B receptors and LTP-generating
enzymes seems unlikely in view of the fact that NVP was
an even more effective blocker of LTP. It is also notable
that both blockers had larger effects on LTP than on any
of the two kinds of depression. Hence, it could be that dif-
ferent forms of plasticity are differentially sensitive to gen-
eral reduction of the NMDA response, depending on the
functional connection between different induction pat-
terns and specific enzymes.
Even LTP by itself appears to have different sensitivity to
NMDAR blockade depending on different induction pro-
tocols. For instance, it was shown that tetanus-induced
LTP in the ACC was partially blocked, whereas theta-
burst-induced LTP was fully blocked by either NVP or Ro
[21]. Another recent study demonstrated that tetanus-
induced LTP was reduced by either NVP or Ro whereas
pairing-induced LTP was unaffected [27]. Moreover, LTP
has been reported to be more sensitive than LTD to partial
block by AP5 [[18], see also discussion in [20]].BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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Specificity of NR2 blocking drugs
This study is based on using NMDAR blockers with specif-
icity for either NR2A- or NR2B-containing heteromers.
With respect to possible cross-effects, the NR2B inhibitors
Ro and Ife are trouble-free since they are more than hun-
dredfold (Ife) or thousandfold (Ro) more selective for
NR2B as compared to NR2A [34,35]. The published data
suggest that the concentrations of 3 μM (Ife) or 0.5 μM
(Ro) that we used are adequate. Regarding NVP, experi-
ments on recombinant human NMDARs expressed in
oocytes indicated a reasonably high selectivity of the drug,
about 130-fold for NR2A versus NR2B [36]. In contrast,
similar experiments expressing rodent NMDA receptors in
either oocytes or HEK-293 cells revealed a smaller ratio,
around 13–14-fold [29,37]. NVP at 0.4 uM concentration,
i.e. the same as used in the present study, was shown to
block most of the response of NR2A-expressing cells, as
measured by Ca2+ imaging, down to a few percent of con-
trol [29]. However, the response of NR2B-expressing cells
to the same NVP concentration was also affected, being
decreased by about 35–40% [29]. Assuming that similar
cross-effects applied to our case, the obtained value of
19% remaining NMDA response after NVP treatment
actually implies around 30% in a theoretical case without
cross-effect. This value fits well with our finding that 68%
of the NMDA response remained after Ro/Ife treatment,
i.e. a reduction by 32%. This nice agreement may be partly
a chance fit since there are complicating factors, such as
the unknown blockade of mixed NR1/NR2A/NR2B heter-
omers, and a higher cross-reaction reported in other work
on HEK293 cells [20]. Additionally, a study of NVP effects
in mutant NR2A-deficient mice also reported that the
drug was effective in blocking NR2B-receptors, and argued
for careful interpretation of data when using NVP [26]. To
some extent, the limited selectivity of NVP may weaken
our conclusion that NR2B receptors can support LTP/LTD
under NVP blockade in facilitation experiments, consider-
ing that residual NR2A current would not be negligible
compared to the remaining NR2B response. However, the
general idea of NR2A dominanting over NR2B remains
valid. Moreover, our comparison between blockade of
responses and blockade of synaptic plasticity ought to be
unaffected by cross-effects, since both cases would be
influenced in a similar manner.
Properties of depotentiation
Depotentiation refers to the erasure of LTP by stimulation
applied after the induction. Previous studies have shown
that depotentiation can be induced by stimulation similar
to that used for inducing LTD [38]. Induction of depoten-
tiation is generally believed to be NMDA-dependent
although there are also reports on NMDA-independent
depotentiation, e.g. selectively involving AMPA receptors
[39-41]. In the present case we studied depotentiation
induced by application of NMDA and examined its sensi-
tivity to NR2A and NR2B inhibitors, since not much atten-
tion has been paid to this issue previously. It can also be
noted that depotentiation has mostly been described in
terms of changes of the tetanized pathway, whereas in the
present study, we also considered the relation between
two pathways as a suitable estimate for studying depoten-
tiation and repotentiation. Although the used test/control
ratio is "contaminated" by the LTD of the control path-
way, it has the advantage that any unspecific plasticity
unrelated to LTP or LTD is eliminated. As described
below, the results can be more easily understood by
hypothesizing the existence of a superimposed, unspecific
depression.
Let us consider some essential features of depotentiation
that emerged from our results in normal solution. It can
be noted that NMDA application caused depotentiation
independent of the estimate used, i.e. test vs. test/control,
even though the values differed. The estimates were taken
under stable conditions after full recovery of responses
after NMDA application. However, in view of the similar
time courses of the recovery of test and control pathways
(see Fig. 5A) we hypothesize that both NMDA-induced
LTD and depotentiation were established early after
NMDA application but were confounded by the recovery
from extinction, constituting an early transient depression
that attenuated test and control responses in a parallel
manner. Interestingly, assuming that this hypothesized
depression also has a stable part may help us to under-
stand the "annoying fact" that repotentiation after
NMDA-induced depotentiation is only partial [9], as also
confirmed by the present work. A simple explanation
would be that LTP was not fully depotentiated and that
the apparent full depotentiation was due to a mixture of
true depotentiation and the hypothesized depression. In
accord with this view, when using relative estimates in
terms of test/control, the original LTP was fully reinstated
or even overexpressed by the second tetanus. The latter
reflects the fact that comparison was made with a
depressed pathway. Further work is needed to interrogate
the idea of multiple depression mechanisms.
When it comes to the role of NR2A and NR2B subunits,
we found that the NMDA-induced depotentiation was
largely blocked by NVP but was little influenced by Ro/Ife,
suggesting predominant involvement of NR2A-contain-
ing NMDARs. This agrees with a previous study on depo-
tentiation induced by "conventional" LFS [19]. The major
contribution of NR2A subunits is also in accord with with
our primary finding that NVP but not Ro/Ife blocked
NMDA-induced LTD, confirmed by the control pathway
data in depotentiation experiments. It so appears that the
induction properties of depotentiation and LTD are simi-
lar, at least with respect to NMDAR subtype involvement.
As might be expected, repotentiation after NMDA-BMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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induced depotentiation was fully blocked by NVP
whereas Ro/Ife had only a partial effect. The reasoning is
that repotentiation would be equivalent to de novo
potentiation, except for a possible difference in baseline
level. However, in the case of NVP, the fact that this base-
line (before the second tetanus) was largely devoid of
depotentiation provides a complementary explanation for
the lack of repotentiation. In future studies, a set of similar
repotentiation experiments, but with NVP applied after
the NMDA-induced depotentiation, should give us a bet-
ter view of how NVP affects repotentiation. Futhermore, it
is not known whether larger repotentiation would be pos-
sible in NVP solution under conditions of facilitated
induction, in analogy with our results on LTP and LTD.
It can also be observed that the level of LTP after repoten-
tiation in Ro/Ife solution was substantially less than in the
normal case. This was especially noticeable when using
relative estimates (test/control). As discussed above, rela-
tive estimates suggest that full recovery of LTP may be pos-
sible after repotentiation. Hence, it remains to find out
whether repeated tetanization in the presence of Ro/Ife,
after NMDA application, would be able to fully restore the
initial level of LTP.
Conclusion
By studying the involvement of NMDAR-subunits in sev-
eral forms of NMDA-dependent synaptic plasticity we
arrive at some general ideas about the integration of post-
synaptic signals in the Schaffer-collateral pathway of 2-
week-old rats. We conclude that NR2A- and NR2B-con-
taining NMDARs mediate most of the NMDA response,
with NR2A dominating over NR2B. Similarly, both NR2A-
and NR2B-type receptors can participate in triggering syn-
aptic plasticity, but NR2A showing a foremost contribu-
tion to all the forms of synaptic plasticity tested here. Our
results support a scenario in which Ca2+ influx, entering
the dendritic spine via different NMDAR heteromers,
sums into a "final common pathway" that controls synap-
tic plasticity by its magnitude and temporal pattern
regardless of the source.
Methods
Slice preparation and maintenance
Hippocampal slices were prepared from Sprague-Dawley
rats aged 12–18 postnatal days, including both males and
females. Animal handling complied with the guidelines of
the Swedish Central Council for Laboratory Animals and
was approved by the local Ethical Committee for Animal
Research. After initial isoflurane (Forene) anesthesia and
decapitation, the brain was removed and placed in an ice-
cold artificial cerebrospinal fluid (ACSF) solution com-
posed of (in mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2,
1 NaH2PO4, 26 NaHCO3 and 10 glucose. Transverse hip-
pocampal slices (400 μm) were cut using a vibrating tissue
slicer (Campden Instsruments) and transferred to the
holding chamber, containing the same ACSF as above and
gassed with 95% O2, 5% CO2. Slices were stored in the
holding chamber at room temperature for at least 1 h
before the experiments. For field potential recording,
slices were individually transferred to one or several "sub-
merged type" recording chambers, perfused at 30–32°C
by the same solution and gas components as above,
except that Ca2+ was 2 or 2.5 mM, and Mg2+ was 1.3, 0.1
or 0.01 mM depending on needs. Perfusion speed was 1.5
ml per min. AMPA EPSPs were normally recorded in ACSF
with 2.5 mM Ca2+ and 1.3 mM Mg2+. Composite AMPA-
NMDA EPSP recording used 2.0 mM Ca2+, 0.1 mM (or
0.01 mM) Mg2+ to facilitate the NMDA response. In this
case, a low concentration of CNQX (0.5–1 μM) was also
present to partially block the AMPA response, leading to a
balanced mixture of AMPA and NMDA components. Iso-
lated NMDA-EPSPs were obtained with 2.0 mM Ca2+, 0.1
mM Mg2+, and 10 μM CNQX to fully block the AMPA
component.
Stimulation and recording
Field excitatory postsynaptic potentials (EPSPs) were
recorded from the CA1 apical dendritic layer using a glass
micropipette filled with perfusion solution (ACSF) or 1–3
M NaCl, 2–5 Mohm resistance. Stimulation, usually
repeated once per 10, 30 or 60 s, was delivered as 0.1 ms
negative constant current pulses (10–50 μA), via one or
two monopolar tungsten electrodes to Schaffer-collateral
axons. In two-pathway experiments, the stimulating elec-
trodes were positioned symmetrically on each side of the
recording elcctrode, allowing alternating activation of two
nonoverlapping sets of synapses. The rate of stimulation
was maintained throughout the experiment except for
periods of LTP induction. LTP was induced by three suc-
cessive tetani (100 Hz, 100 impulses each) repeated with
an interval of 5 s in between the trains. NMDA-induced
LTD was acheived by a brief (4 min) application of NMDA
(30–40 μM). In "slow LTD" experiments, the stimulus fre-
quency was kept constant at 0.1 Hz and NMDA-depend-
ent induction was brought about by pharmacological
unblocking of NMDARs for 1–2 h by help of a low Mg2+
solution (usually 0.1 mM). Stability of recordings was ver-
ified for at least 1 h before beginning the actual experi-
ment.
Data Analysis
Signals were amplified, filtered and transferred to a PC
clone computer for on-line and off-line analysis by spe-
cially designed electronic equipment (based on an Eagle
Instruments multifunction board) and own developed
computer software. AMPA EPSPs, as well as the AMPA
component of composite EPSPs, were measure using a
time window of 0–1.5 ms after the fiber volley. The
NMDA component of composite EPSPs was measuredBMC Neuroscience 2007, 8:55 http://www.biomedcentral.com/1471-2202/8/55
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with a 35–45 ms window whereas isolated NMDA-EPSPs
were measured using a window of 0–5 ms after the fibre
volley. Measurements were calculated by integrating the
EPSP curve along the specified time window after subtrac-
tion of the prestimulus baseline, yielding the area under
the curve. This measure can also be viewed as the "initial
amplitude" and has similar properties as "initial slope".
Values were corrected by subtracting the corresponding
measurements of the nonsynaptic potential, obtained
after total blockage of the EPSP by 10 μM CNQX and 50
μM AP5. In most cases, the traces used for illustration
were also corrected by the nonsynaptic potential. Synaptic
plasticity was generally estimated as ratio between post-
and pre-induction values after averaging responses for 5–
10 min periods. In two-pathway experiments, the ratio
between pathways was sometimes used. In some experi-
ments with NMDA component recording, there was no
preinduction baseline available to be used as 100%. In
this case the maximum level was generally used as 100%.
Additional scaling of this level was performed in experi-
ments with NMDA subunit blockers to include the effect
of the blocker. Data are presented as mean ± S.E.M. Statis-
tical comparisons were made using Student's t-test. Statis-
tical significance was set at p < 0.05.
Drugs
CNQX and AP5 were obtained from Tocris Cookson, UK;
Ro25-6981 and Ifenprodil were from Sigma Chemicals
Co., MO, USA. NVP-AAM077 was generously supplied by
Novartis Pharmaceuticals. Prefabricated stimulating elec-
trodes were obtained from World Precision Instruments,
FL, USA, type TM33B.
Abbreviations
AMPA:  α-amino-3-hydroxy-5-methyl-4-isoxazolepropi-
onic acid
AP5: D(-)-2-amino-5-phosphonopentanoic acid
CNQX: 6-cyano-7-nitroquinoxaline-2,3-dione
EPSP: excitatory postsynaptic potential
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